Rapamycin抑制剂

HY-10219Rapamycin抑制剂

参考价: ¥550~¥605

具体成交价以合同协议为准
2023-05-22 15:22:23
225
属性:
CAS号:53123-88-9;产地:进口;级别:其他;证书:ISO系列证书;
>
规格:
10;10;
>
产品属性
CAS号
53123-88-9
产地
进口
级别
其他
证书
ISO系列证书
关闭
Rapamycin抑制剂

参考价: ¥550~¥605

10 605元 10000 支可售
10 550元 10000 支可售
x
杭州昊鑫生物科技股份有限公司

杭州昊鑫生物科技股份有限公司

免费会员
收藏

组合推荐相似产品

产品简介

Rapamycin抑制剂
Rapamycin 是一种有效且特异性的 mTOR 抑制剂,作用于 HEK293 细胞,抑制 mTOR,IC50 为 0.1 nM。Sirolimus 与 FKBP12 结合且抑制 mTORC1。Rapamycin 还是一种自噬 (autophagy) 激活剂,免疫抑制剂。

详细介绍

注:本产品仅用于科研,不可用于临床


生物活性

Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant

体外研究
(In Vitro)

Rapamycin(12.5-100 nM;24 小时)处理在所有测试的细胞系(A549、SPC-A-1、95D 和 NCI-H446 细胞)中以剂量依赖性方式对肺癌细胞增殖产生适度抑制作用,达到约 100 nM 时细胞增殖减少 30-40%,而 12.5 nM 时减少约 10%[3]
将肺癌细胞系 95D 细胞单独或联合暴露于 Rapamycin(10 nM、20 nM)和 RP-56976(1 nM、10 nM)(Rapamycin 20 nM + RP-56976 10 nM)。单独暴露于 Rapamycin 或 RP-56976 24 小时后,不会显着改变 ERK1/2 的表达或磷酸化水平,而 Rapamycin 与 RP-56976 联合处理的细胞表现出 ERK1/2 磷酸化水平的显着降低[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[3]

Cell Line:Lung cancer cell lines A549, SPC-A-1, 95D and NCI-H446
Concentration:12.5 nM, 25 nM, 50 nM, 100 nM
Incubation Time:24 hours
Result:Treatment exerted modest inhibitory effect on lung cancer cell proliferation in a dose-dependent manner in all cell lines.









体内研究
(In Vivo)

Rapamycin (2.0 mg/kg; 腹腔内注射; 每隔一天;28 天) 单独使用有中等的抑制作用。然而,与对照组、Rapamycin 组相比,metformin联合 Rapamycin 对肿瘤生长的抑制作用明显增强[4]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Animal Model:24 male nu/nu mice aged 4-5 week old (15-20 g)[4]
Dosage:2.0 mg/kg
Administration:Intraperitoneal injection; every other day; 28 days
Result:Had a moderate inhibitory effect in monotherapy group. The combination with Metformin exerted a significantly increased inhibition of tumor growth.










Clinical Trial

NCT NumberSponsorConditionStart DatePhase
NCT03826628Dermatology Specialties Limited Partnership
Facial Angiofibroma|Tuberous Sclerosis
July 28, 2019Phase 2|Phase 3
NCT05556681C. R. Bard
Peripheral Arterial Disease|Peripheral Artery Disease|Stenosis Artery
August 2, 2022
NCT01223755Mario Negri Institute for Pharmacological Research
Autosomal Dominant Polycystic Kidney Disease (ADPKD)















分子量

914.17

性状

Solid

Formula

C51H79NO13

CAS 号

53123-88-9

中文名称

雷帕霉素;sirolimus

来源

bacterium Streptomyces hygroscopicus

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder-20°C3 years

4°C2 years
In solvent-80°C

6 months


-20°C

1 months







上一篇:Acid-PEG-NHS,羧基 PEG 活性酯,分子量:1000,2000,3400 下一篇:39927-08-7,Acid-PEG-acidMW1000,2000,两端羧基聚乙二醇
热线电话 在线询价
提示

请选择您要拨打的电话: